Unraveling the directional link between adiposity and inflammation: A bidirectional mendelian randomization approach

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 93-99

  Welsh, Paul ^a   Polisecki, Eliana ^b   Robertson, Michele ^a   Jahn, Sabine ^b   Buckley, Brendan M ^c   De Craen, Anton J M ^d   Ford, Ian ^a   Jukema, J Wouter ^d   Macfarlane, Peter W ^a   Packard, Chris J ^a   Stott, David J ^a   Westendorp, Rudi G J ^d   Shepherd, James ^a   Hingorani, Aroon D ^e   Smith, George Davey ^f   Schaefer, Ernst ^b   Sattar, Naveed ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LEPTIN; MELANOCORTIN 4 RECEPTOR;

AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FTO GENE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 75149163834     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1064     Document Type: Article

References (41)

1. Li S, Loos RJ 2008 Progress in the genetics of common obesity: size matters. Curr Opin Lipidol 19:113-121
2. Smith GD, Timpson N, Ebrahim S 2008 Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization. Ann Med 40:524-541
3. Davey Smith G, Ebrahim S 2003 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1-22
4. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G 2008 Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133-1163
5. Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S 2007 Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 4:e352
6. Verzilli C, Shah T, Casas JP, Chapman J, Sandhu M, Debenham SL, Boekholdt MS, Khaw KT, Wareham NJ, Judson R, Benjamin EJ, Kathiresan S, Larson MG, Rong J, Sofat R, Humphries SE, Smeeth L, Cavalleri G, Whittaker JC, Hingorani AD 2008 Bayesian metaanalysis of genetic association studies with different sets of markers. Am J Hum Genet 82:859-872
7. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI 2007 A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889-894
8. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, Berndt SI, Jacobs KB, Chanock SJ, Hayes RB, Bergmann S, Bennett AJ, Bingham SA, Bochud M, Brown M, Cauchi S, Connell JM, Cooper C, Smith GD, Day I, Dina C, De S, Dermitzakis ET, Doney AS, Elliott KS, Elliott P, Evans DM, Sadaf Farooqi I, Froguel P, Ghori J, Groves CJ, Gwilliam R, Hadley D, Hall AS, et al. 2008 Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40:768-775
9. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN 2008 An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 359:2558-2566
10. Qi L, Kraft P, Hunter DJ, Hu FB 2008 The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women. Hum Mol Genet 17:3502-3508
11. Timpson NJ, Emmett PM, Frayling TM, Rogers I, Hattersley AT, McCarthy MI, Davey Smith G 2008 The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr 88:971-978
12. Wardle J, Llewellyn C, Sanderson S, Plomin R 2009 The FTO gene and measured food intake in children. Int J Obes (Lond) 33:42-45
13. Hingorani A, Humphries S 2005 Nature's randomised trials. Lancet 366:1906-1908
14. Hingorani AD, Shah T, Casas JP 2006 Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk. Eur Heart J 27:1261-1263
15. Welsh P, Woodward M, Rumley A, Lowe G 2008 Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 141:852-861
16. Hamer M, Steptoe A 2009 Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women. Am J Clin Nutr 89:85-89
17. Wärnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR, Ortega FB, Sjöström M, Bueno M, Marcos A 2006 Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 84:505-512
18. Rogge MM 2002 The case for an immunologic cause of obesity. Biol Res Nurs 4:43-53
19. Pepys MB, Hawkins PN, Kahan MC, Tennent GA, Gallimore JR, Graham D, Sabin CA, Zychlinsky A, de Diego J 2005 Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ Res 97:e97-e103
20. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB 2008 Creactive protein and coronary heart disease: a critical review. J Intern Med 264:295-314
21. Hingorani AD, Shah T, Casas JP, Humphries SE, Talmud PJ 2009 C-reactive protein and coronary heart disease: predictive test or therapeutic target? Clin Chem 55:239-255
22. Phillips AN, Smith GD 1991 How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol 44:1223-1231
23. Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, Jukema JW, Hyland M, Gaw A, Lagaay AM, Perry IJ, Macfarlane PW, Meinders AE, Sweeney BJ, Packard CJ, Westendorp RG, Twomey C, Stott DJ 1999 The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol 84:1192-1197
24. Hardy R, Kuh D 2006 Commentary: BMI and mortality in the elderly - a life course perspective. Int J Epidemiol 35:179-180
25. Micozzi MS, Harris TM 1990 Age variations in the relation of body mass indices to estimates of body fat and muscle mass. Am J Phys Anthropol 81:375-379
26. Shimizu H, Shimomura Y, Hayashi R, Ohtani K, Sato N, Futawatari T, Mori M 1997 Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obes Relat Metab Disord 21:536-541
27. Hubacek JA, Bohuslavova R, Kuthanova L, Kubinova R, Peasey A, Pikhart H, Marmot MG, Bobak M 2008 The FTO gene and obesity in a large Eastern European Population sample: the HAPIEE study. Obesity (Silver Spring) 16:2764-2766
28. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG 2002 Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360:1623-1630
29. Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J 2007 C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115:981-989
30. Welsh P, Murray HM, Buckley BM, de Craen AJ, Ford I, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Sattar N 2009 Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 32:308-310
31. Sieh W, Yu CE, Bird TD, Schellenberg GD, Wijsman EM 2007 Accounting for linkage disequilibrium among markers in linkage analysis: impact of haplotype frequency estimation and molecular haplotypes for a gene in a candidate region for Alzheimer's disease. Hum Hered 63:26-34
32. Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, Miller M, Lowe GD, Rumley A, Casas JP, Shah T, Humphries SE, Hingorani AD, Marmot MG, Timpson NJ, Kumari M2008 Inflammation, insulin resistance, and diabetes - Mendelian randomization using CRP haplotypes points upstream. PLoS Med 5:e155
33. Drenos F, Talmud PJ, Casas JP, Smeeth L, Palmen J, Humphries SE, Hingorani AD 2009 Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet 18:2305-2316
34. Birjmohun RS, Bisoendial RJ, van Leuven SI, Ackermans M, Zwinderman A, Kastelein JJ, Stroes ES, Sauerwein HP 2007 A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans. Metabolism 56:1576-1582
35. Timpson NJ, Harbord R, Davey Smith G, Zacho J, Tybjaerg-Hansen A, Nordestgaard BG 2009 Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO/MC4R genotype. Hypertension 54:84-90
36. Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, Ruokonen A, Ebrahim S, Shields B, Zeggini E, Weedon MN, Lindgren CM, Lango H, Melzer D, Ferrucci L, Paolisso G, Neville MJ, Karpe F, Palmer CN, Morris AD, Elliott P, Jarvelin MR, Smith GD, McCarthy MI, Hattersley AT, Frayling TM 2008 Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 57:1419-1426
37. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, Hattersley AT, Ebrahim S, Lowe GD, Rumley A, Davey Smith G 2005 C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 366:1954-1959
38. Timpson NJ, Sayers A, Davey-Smith G, Tobias JH 2009 How does body fat influence bone mass in childhood? A Mendelian randomisation approach. J Bone Miner Res 24:522-533
39. Pepys MB 2008 C-reactive protein is neither a marker nor a mediator of atherosclerosis. Nat Clin Pract Nephrol 4:234-235
40. Tennent GA, Hutchinson WL, Kahan MC, Hirschfield GM, Gallimore JR, Lewin J, Sabin CA, Dhillon AP, Pepys MB 2008 Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE -/- mice. Atherosclerosis 196:248-255
41. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Rumley A, Lowe GD, Day IN, Ebrahim S 2005 Association of C-reactive protein with blood pressure and hypertension: life course confounding and Mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 25:1051-1056